RSS Worldwide Bio News

  • MS-related Vertigo: What Can You Do?
    This post was originally published on this site I’ve never liked carnival rides (except for roller coasters) because they make me dizzy. Walking sideways, feeling nauseous, and turning green is not my idea of a fun time! So, I go out of my way to avoid anything that can make my head spin. Yet, for […]
  • Abdominal Chemotherapy Perfusion Effective on Treatment-resistant, Recurrent OC in Phase 2 Study
    This post was originally published on this site Localized chemotherapy perfusion in the abdomen showed efficacy in patients with treatment-resistant and recurrent ovarian cancer, according to preliminary results of an ongoing Phase 2 clinical study. A subset of the patients showed complete cancer remission. The study, “Hypoxic isolated abdominal perfusion breaks through chemoresistance in recurrent […]
  • FDA Grants Poseida’s P-BCMA-101 RMAT Status for Treatment of Multiple Myeloma
    This post was originally published on this site The U.S. Food and Drug Administration (FDA) has granted P-BCMA-101, Poseida Therapeutics’ CAR T-cell therapy and lead product candidate, the Regenerative Medicine Advanced Therapy (RMAT) designation for the treatment of relapsed or refractory multiple myeloma. Preliminary results from a Phase 1 trial (NCT03288493) suggest the candidate is safe and […]
  • My Husband and I Are Each Other’s Keepers
    This post was originally published on this site Today, I became my husband’s dependent — officially. A few months ago, I wrote about being ineligible for health insurance because I was already five months pregnant when I applied for it. My only option was to register as my husband’s dependent. That meant he would have […]
  • My Guide to Endoscopies for Crohn’s, Part 2
    This post was originally published on this site Second in a series. Read part one. For the past few weeks, I have been experiencing more abdominal pain than usual, so my gastroenterologist has ordered a colonoscopy. Although I usually have a colonoscopy every two years, my doctor wants to monitor the status of my Crohn’s […]
  • Answering the Questions Friends Ask Most Often About My Friedreich’s Ataxia
    This post was originally published on this site Over the past couple of weeks, I’ve had some good conversations with FAers and others about life. I was asked similar questions in each conversation, so I figured those topics must cross other people’s minds. Perhaps my answers can give you insight into my personality and who […]
  • Adventures with Anaphylaxis
    This post was originally published on this site Every time I think I’ve run out of things to write about, life throws me a curveball. Over the past couple of years, I’ve been getting allergy shots on a pretty regular basis. The science behind allergy shots might seem a bit counterintuitive: If you repeatedly expose […]
  • There’s No Cure, but There Is Relief for Me
    This post was originally published on this site Heartburn, acid reflux, indigestion … I feel like a walking Pepto-Bismol commercial. It seems that even water has the ability to cause heartburn — and here I expected it to put that fire out. I have been a sometimes-vegetarian for years, but recently I decided to ditch […]
  • The Bittersweet Downside of CFTR Modulators
    This post was originally published on this site I’ve been on Orkambi (lumacaftor/ivacaftor), a cystic fibrosis transmembrane conductance regulator (CFTR) modulator, for just over three years now. My lung function has remained stable during that time. CFTR modulators are medications that “fix” the defect that causes cystic fibrosis. “Fixing” the defect means improving CFTR function. […]
  • Orkambi Closer to Being Approved in Europe to Treat Children Ages 2-5 With Cystic Fibrosis
    This post was originally published on this site The European Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Orkambi (lumacaftor/ivacaftor) as a treatment for children ages 2-5 with cystic fibrosis (CF) due to F508del mutations, Vertex Pharmaceuticals announced. CHMP’s positive opinion will be taken into consideration by the European Medicines Agency, which will […]